Search research articles
Contact Us
Filters
Showing results (31-40 of 56) with videos related to
Page
of 6
Sort By:
Addiction (Abingdon, England)
|
June 11, 2017
Loose regulation of medical marijuana programs associated with higher rates of adult marijuana use but not cannabis use disorder
Arthur Robin Williams, Julian Santaella-Tenorio, Christine M Mauro, et al.
The American Journal of Drug and Alcohol Abuse
|
February 22, 2024
Application of an opioid use disorder cascade of care in a large public health system
Emily Carter, Daniel Schatz, Noah Isaacs, et al.
The American Journal on Addictions
|
September 9, 2020
Commentary: Proposed Model State Cannabis Laws to Reduce Harms
Arthur Robin Williams, Kevin P Hill, Richard N Rosenthal, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 31, 2023
Application of an Opioid Use Disorder Cascade of Care in a Large Public Health System
Emily Carter, Daniel Schatz, Noah Isaacs, et al.
JAMA Health Forum
|
July 28, 2023
Urine Drug Screening in a Telehealth Setting for the Treatment of Opioid Use Disorder
Arthur Robin Williams, Christopher Rowe, Ryan Gallagher, et al.
Cannabis and Cannabinoid Research
|
April 29, 2022
Adult Medical Cannabinoid Use and Changes in Prescription Controlled Substance Use
Arthur Robin Williams, Christine M Mauro, Tianshu Feng, et al.
Health Affairs Scholar
|
March 7, 2024
Use of in-network insurance benefits is critical for improving retention in telehealth-based buprenorphine treatment
Arthur Robin Williams, Christopher Rowe, Lexie Minarik, et al.
Addiction Science & Clinical Practice
|
March 17, 2024
Treatment setting and buprenorphine discontinuation: an analysis of multi-state insurance claims
Kevin Y Xu, Alex K Gertner, Shelly F Greenfield, et al.
The American Journal of Psychiatry
|
May 6, 2024
Defining Discontinuation for Buprenorphine Treatment: Implications for Quality Measurement
Arthur Robin Williams, Christine M Mauro, Ben Huber, et al.
Pharmacoepidemiology and Drug Safety
|
December 26, 2025
Identifying Extended-Release Naltrexone Treatment for Opioid Use Disorder in US Medicaid Data
Rachael K Ross, Anne M Butler, Marissa J Seamans, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 56) with videos related to
Sort By:
Page
of 6
Addiction (Abingdon, England)
|
June 11, 2017
Loose regulation of medical marijuana programs associated with higher rates of adult marijuana use but not cannabis use disorder
Arthur Robin Williams, Julian Santaella-Tenorio, Christine M Mauro, et al.
The American Journal of Drug and Alcohol Abuse
|
February 22, 2024
Application of an opioid use disorder cascade of care in a large public health system
Emily Carter, Daniel Schatz, Noah Isaacs, et al.
The American Journal on Addictions
|
September 9, 2020
Commentary: Proposed Model State Cannabis Laws to Reduce Harms
Arthur Robin Williams, Kevin P Hill, Richard N Rosenthal, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 31, 2023
Application of an Opioid Use Disorder Cascade of Care in a Large Public Health System
Emily Carter, Daniel Schatz, Noah Isaacs, et al.
JAMA Health Forum
|
July 28, 2023
Urine Drug Screening in a Telehealth Setting for the Treatment of Opioid Use Disorder
Arthur Robin Williams, Christopher Rowe, Ryan Gallagher, et al.
Cannabis and Cannabinoid Research
|
April 29, 2022
Adult Medical Cannabinoid Use and Changes in Prescription Controlled Substance Use
Arthur Robin Williams, Christine M Mauro, Tianshu Feng, et al.
Health Affairs Scholar
|
March 7, 2024
Use of in-network insurance benefits is critical for improving retention in telehealth-based buprenorphine treatment
Arthur Robin Williams, Christopher Rowe, Lexie Minarik, et al.
Addiction Science & Clinical Practice
|
March 17, 2024
Treatment setting and buprenorphine discontinuation: an analysis of multi-state insurance claims
Kevin Y Xu, Alex K Gertner, Shelly F Greenfield, et al.
The American Journal of Psychiatry
|
May 6, 2024
Defining Discontinuation for Buprenorphine Treatment: Implications for Quality Measurement
Arthur Robin Williams, Christine M Mauro, Ben Huber, et al.
Pharmacoepidemiology and Drug Safety
|
December 26, 2025
Identifying Extended-Release Naltrexone Treatment for Opioid Use Disorder in US Medicaid Data
Rachael K Ross, Anne M Butler, Marissa J Seamans, et al.
Page
of 6